PATENT CLAIM ANALYSIS

Application Number: 15937271
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "210180"]

Abstract:
The present invention relates to inhibitors of bromo and extra terminal (BET) bromodomains that are useful for the treatment of cancer, inflammatory diseases, diabetes, and obesity, having Formula I: wherein W, X, Y, Z, R 1 , R 2 , R 5 , and R 8  are as described herein.

Claim (Index 23):
The method of  claim 22 , wherein said disease or disorder is selected from the group consisting of cancer, inflammatory disorders, irritable bowel syndrome, inflammatory bowel disease, rheumatoid arthritis, obesity, and diabetes.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 90.0
- Lexical Diversity: 1.37778
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14546775', '14546896', '12641063', '13347364', '15757199']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8464980680184381
- 35 USC 102 Novelty (BERT): 0.582739660510771
- Combined Prediction Score: 0.8201222272676714
- Mean Citation Score: 423.176318
- Max Citation Score: 655.55743
- Similarity Product: 399.5259085767084

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test